Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ANGELA E SCHEUERLE

Allopathic & Osteopathic Physicians Pediatrics

NPI
1073570586
CMS profile
320386
Location
DALLAS, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$16,804.81

98 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

By paying entity

PY2020 · entire year · sorted by reported total

Paying entityAmountRecords
UCB SA $11,875.00 11
ViiV Healthcare Company $1,553.61 13
AbbVie Inc. $553.62 12
Merck Sharp & Dohme Corporation $553.62 12
Hikma Pharmaceuticals USA $548.06 12
Mylan Inc. $513.44 11
Sandoz Inc. $513.44 11
Boehringer Ingelheim Pharmaceuticals, Inc. $348.94 8
Lupin Inc. $288.45 6
Gilead Sciences, Inc. $40.18 1
GENZYME CORPORATION $16.45 1

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

98 matching records · $16,804.81 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 98 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 98.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Hikma Pharmaceuticals USA $34.6212/27/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261062027357 CMS
UCB SA $250.0012/23/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026746118639 CMS
AbbVie Inc. $20.1912/01/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026722113775 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $20.1912/01/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026748512001 CMS
Merck Sharp & Dohme Corporation $20.1912/01/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747828777 CMS
Mylan Inc. $20.1912/01/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026751388671 CMS
Sandoz Inc. $20.1912/01/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026717740165 CMS
ViiV Healthcare Company $20.1912/01/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026753929636 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $95.1911/30/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026748511995 CMS
UCB SA $500.0011/26/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026746118315 CMS
Hikma Pharmaceuticals USA $20.1911/24/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261062027355 CMS
UCB SA $250.0011/05/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026746118297 CMS
AbbVie Inc. $95.1911/03/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026722113773 CMS
Merck Sharp & Dohme Corporation $95.1911/03/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747828779 CMS
Mylan Inc. $95.1911/03/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026751388669 CMS
Sandoz Inc. $95.1911/03/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026717740167 CMS
ViiV Healthcare Company $95.1911/03/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026753929620 CMS
Hikma Pharmaceuticals USA $95.1910/30/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261062027354 CMS
AbbVie Inc. $57.6910/01/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026722113771 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $57.6910/01/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026720412915 CMS
Merck Sharp & Dohme Corporation $57.6910/01/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747768577 CMS
Mylan Inc. $57.6910/01/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026751385815 CMS
Sandoz Inc. $57.6910/01/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026717740161 CMS
UCB SA $750.0010/01/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026746118537 CMS
ViiV Healthcare Company $57.6910/01/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026733134461 CMS
Hikma Pharmaceuticals USA $57.6909/21/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261062027353 CMS
UCB SA $750.0009/10/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026746118525 CMS
AbbVie Inc. $11.5409/01/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026722113769 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $11.5409/01/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026720412912 CMS
Merck Sharp & Dohme Corporation $11.5409/01/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747768573 CMS
Mylan Inc. $11.5409/01/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026751385813 CMS
Sandoz Inc. $11.5409/01/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026717740163 CMS
ViiV Healthcare Company $11.5409/01/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026733142617 CMS
Hikma Pharmaceuticals USA $11.5408/29/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261062027356 CMS
AbbVie Inc. $40.3808/01/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026722113767 CMS
Merck Sharp & Dohme Corporation $40.3808/01/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747768575 CMS
Mylan Inc. $40.3808/01/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026751385811 CMS
Sandoz Inc. $40.3808/01/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026717740159 CMS
ViiV Healthcare Company $40.3808/01/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026733145467 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $40.3807/31/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026720980211 CMS
Hikma Pharmaceuticals USA $40.3807/31/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261062027352 CMS
UCB SA $500.0007/30/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026746118507 CMS
UCB SA $2,750.0007/30/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026746118509 CMS
AbbVie Inc. $20.1907/01/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026722113765 CMS
Lupin Inc. $20.1907/01/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: CHANGED
06/30/2026719545163 CMS
Merck Sharp & Dohme Corporation $20.1907/01/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747624961 CMS
Mylan Inc. $20.1907/01/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026751385215 CMS
Sandoz Inc. $20.1907/01/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026717740173 CMS
Hikma Pharmaceuticals USA $20.1906/26/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261062027348 CMS
ViiV Healthcare Company $20.1906/26/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026733135639 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $14,528.66 174
PY2020 $16,804.81 98
PY2021 $20,730.19 81
PY2022 $12,508.14 67
PY2023 $11,114.37 101
PY2024 $29,910.23 86
PY2025 $11,922.07 78

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
ANGELA E SCHEUERLE, NPI 1073570586. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1073570586.
APA 7
IndustryPayments. (2026). ANGELA E SCHEUERLE, NPI 1073570586 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1073570586
Bluebook
ANGELA E SCHEUERLE, NPI 1073570586, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1073570586.

Source: Centers for Medicare & Medicaid Services, Open Payments.